Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

162
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 04:46am US/Eastern

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
11h ago Lilly must divest Sentinel products after FTC nod on Novartis deal
11h ago GLAXOSMITHKLINE : GSK announces US regulatory submission seeking additional indi..
13h ago GLAXOSMITHKLINE : Glaxo Submits Supplemental New Drug Application For Eltrombopa..
1d ago Fear factor fades as global M&A hits seven-year high
3d ago GLAXOSMITHKLINE : Assigned Patent
4d ago GSK shareholders approve asset swap deal with Novartis
4d agoDJGLAXOSMITHKLINE : Glaxo : Study of Shingles Vaccine Meets Primary Objective
4d ago GLAXOSMITHKLINE : Glaxo Says Phase III Shingles Candidate Vaccine Trial Met Endp..
4d ago GLAXOSMITHKLINE : Pivotal phase III study of GSK shingles candidate vaccine meet..
5d agoDJFrance Told To Do More for Foreign Investors
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF